Mutation in Biological Technology
Navigation Links
Mutation in Biological Technology
PTC Therapeutics Receives $2.6 Million in Government Grants
... trial of ataluren (PTC124(TM)) in nonsense mutation Duchenne and Becker muscular dystrophy ... as a new approach for the treatment of nonsense mutation genetic disorders. Nonsense mutations create a ... is a potential therapy for patients with nonsense mutation genetic disorders. Ataluren has demonstrated ...MEDomics Announces MitoDx(TM), the First NextGen Mitochondrial Genome Diagnostic Test
... not suspect the disease or because the causative mutation is missed by current methods. " To my ... S. Sommer, MD, PhD, with the mission of providing mutation Expert-based Diagnosis ("MED") to support the ... analysis of the patient's genome ("omics"). The mutation experts at MEDomics provide unparalleled quality ...Transgenomic, Inc. Announces Appointment of New Board Members
... lab, plus focusing our WAVE system and related mutation detection technology for greater diagnostic and ... automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, ... technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated ...... WAVE DHPLC and Surveyor Nuclease products for mutation detection in cancer and mitochondrial diseases," ... will be particularly valuable in cancer-related mutation detection of free DNA in blood and body fluids and in producing a mutation profile of primary tumors to predict resistance ...
... Transgenomic's Surveyor Nuclease technology for mutation scanning of PKD1 and PKD2 , two important ... Nuclease's effectiveness in disease specific mutation discovery has been well documented in many ... automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, ...
Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
... a full product line of key cancer pathway gene mutation kits to complement our WAVE and Surveyor products ... product combo will be enhanced with specific gene mutation kits based on our experience in clinical trial ... automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, ...VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
... have found an association between a rare gene mutation and heart protection. The information reported in ... journal, Science, identified a specific gene mutation ( APOC3 R19X) present in 5 percent of a ... said participants who were carriers of the mutation had one of their inherited APOC3 genes ...Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
... was observed that individuals carrying a natural mutation of their CCR5 gene, CCR5-delta32, were highly ... matched donors who also carry the CCR5-delta32 mutation are likely to be rare. Small molecule or antibody ... A small fraction of the population carries a mutation in their CCR5 gene, called the delta32 mutation. ...... disease is a familial disease caused by a mutation in the huntingtin gene. Each child of a parent with a mutation in the huntingtin gene has a 50-50 chance of ... One person in 10,000 is believed to carry a mutation in the huntingtin gene. There is currently no way ...
... Individuals carrying a naturally occurring mutation of their CCR5 gene, a variant known as ... individuals carrying the natural CCR5-delta32 mutation were highly resistant to infection by ... A small fraction of the population carries a mutation in their CCR5 gene, called the delta32 mutation. ...
Transgenomic Reports Second Quarter 2008 Results
... from our highly sensitive SURVEYOR Nuclease mutation detection technology. SEAL will prove extremely ... whole genome sequence analyses and a host of key mutation and variation analyses of specific gene targets ... in more than 30 countries. The SURVEYOR(R) mutation Detection Kits and SURVEYOR Check-It Kit provide ...Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests
... K-RAS Mutation Test and TheraScreen EGFR 29 mutation Test. The tests are intended, when considered ... from a specific cancer therapy based on their mutation status. "There is a growing demand for tests to ... treatment decisions." The TheraScreen K-RAS mutation Test was the first clinically validated, CE-Mark ...National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment
... to longer survival. Genzyme will perform the IgVH mutation analysis for the study. "This study is critical ... bone marrow aspirate. Genzyme launched its IgVH mutation analysis test in February, 2007. "CLL is ... Genetics. "By proactively testing for the IgVH mutation soon after initial diagnosis, doctors can ...... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
... collaboration will use DxS' industry leading Scorpions(R) real-time PCR mutation Test Kits in conjunction with ExosomeDX's x OS(TM) technology which ... for predicting patient response to targeted therapies. Blood-based mutation measurement is particularly valuable in circumstances where tissue ...
Transgenomic, Inc. Reports First Quarter 2009 Results
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
Discovery of a new retinal gene involved in childhood blindness
... of fifteen genes involved in LCA, but SPATA7 is the first gene with a mutation that disrupts the protein transport between two important compartments of ... through this transport pathway; thus SPATA7 plays a major role and its mutation may affect many aspects of vision. "Until now we were not aware that ...Transgenomic Awarded Clinical Laboratory Certification in California
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
... products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
... disease amongst Caucasian populations. The disease is caused by a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene found on chromosome 7. This mutation causes increased secretion deposits on mucous membranes. Lung ...Transgenomic Receives Accreditation From College of American Pathologists
... instruments and consumables with our related expertise in high sensitivity mutation detection analysis. We plan to immediately pursue the benefits of the ... Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...Large-scale genetic study sheds new light on lung cancer
... found more than two-thirds of the 188 tumors studied had at least one gene mutation affecting the mitogen-activated protein kinase (MAPK) pathway, indicating ... cancer. However, doctors do know that in some other types of cancer, high mutation levels may cause a tumor to spread rapidly and/or be resistant to ...... medicine. Transgenomics' highly sensitive technologies for DNA mutation detection and analysis are expected to complement and enhance COXEN, which ... Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
... hereditary disease among Caucasian population. The disease is caused by a mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene found on chromosome 7. This mutation causes increased secretion deposits on mucous membranes. Lung ...
... archived for subsequent multi-query analysis. About SURVEYOR SURVEYOR mutation Detection Kits and the SURVEYOR Check-It Kit provide reagents and ... have been shipped to customers in more than 30 countries. The SURVEYOR mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols ...
Biotage Launches New 24 Well Pyrosequencing(R) System
... variation of genes, providing CpG methylation allele quantification and mutation analysis. These studies are used for a wide range of clinical research, ... samples. The 24 well plate format and the ability to run and analyze both mutation and methylation assays on the same plate provides an ideal solution for ...... cells of the immune system. Individuals carrying a naturally occurring mutation of their CCR5 gene, a variant known as CCR5-delta32, have been shown to ... -- so-called "R5" strains. A small fraction of the population carries a mutation in their CCR5 gene, called the delta32 mutation. This mutated version of ...
SEQUENOM Announces Launch of MassARRAY Compact 96 System
... marketing at SEQUENOM. "MassARRAY technology enables detection of the most common molecular biomarker classes - somatic mutations via the OncoCarta mutation panel, SNPs, CNVs, methylation patterns, expression signatures - with an unmatched combination of quantitative accuracy and sensitivity. This is the ...CEL-SCI Corporation Releases Letter to Shareholders
... At this meeting the WHO's Director General was underscoring the unstoppable nature of swine flu and its potential to mutate - "Constant, random mutation is the survival mechanism of the microbial world. Like all influenza viruses, H1N1 has the advantage of surprise on its side." At the same time, the ...... advances in global health. The initiative is highly competitive, receiving more than 3,000 proposals in this round. People born with a genetic mutation in their CCR5 gene, a critical receptor for HIV entry, are naturally resistant to HIV infection. Sangamo has designed and engineered zinc finger ...
Chromosome breakpoints contribute to genetic variation
... other parts of the chromosome. In 2005, Lewin's team showed that breakpoint regions also have higher numbers of segmental duplications, a type of mutation that increases the copy number of genes and the sequences that flank them. "To me, this was completely counterintuitive. I thought we would have ...Patent for Making Combination Chemotherapy Work Better
... Mark Zamoyski of San Jose, California discloses an improved method of treating lung, brain, pancreatic, breast and colon cancers that are driven by a mutation known as HER1 overexpression (also called EGFR or c-ErbB-1). The patent presents a case for why today's concurrent HER1 blocker / S-Phase cytotoxic ...... of Thrombotic Thrombocytopenia Purpura. The laboratory is also searching for genetic modifiers of thrombotic diseases, including the common human mutation Factor V Leiden. Studies of the bleeding disease combined deficiency of factors V and VIII by the Ginsburg lab identified mutations in two genes ...
Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference
... disrupting agent (VDA), CYT997, has also been presented at the same conference. About JAK2 The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a therapy for these diseases through selective inhibition of JAK2. ...Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
... agreement to co-develop novel cell and protein therapies for Hemophilia A. Hemophilia A is an inherited blood clotting disorder caused by a mutation in the factor VIII gene resulting in a deficiency of factor VIII protein. Lentigen and Expression Therapeutics will develop two types of treatments ...Other ContentssomatizationthroatsthroatsthroatssoresoresoresoresoresoysoysoysoyspecimenspecimenspecimenspecimenspecimenspecimenspecimenspecimenspecimenspasmodicspasmodicspasticityspasticityOther TagswisePew
(Date:11/30/2009)..., A team of scientists from The Forsyth Institute... CDC and the Wadsworth Center, have used state-of-...itecture of Treponema pallidum, the bacterium whic... structure of the bacteria can now be shown in thr...of the pathogen and reveals previously unknown fea...
(Date:11/30/2009)..., The Editors of The Journal of Experimental Bio...n from Centre National de la Recherche Scientifiqu... is the winner of this year,s JEB Outstanding Pa... an outstanding achievement and is intended to enc... JEB Editor-in-Chief, and adds that ,we truly ap...
(Date:11/30/2009)..., A major obstacle to HIV research is the virus,s...ing that scientists, traditional tools, like the h...ion. Now, a team of researchers writing in BioMed ...de an ingenious assault on this problem by creatin...ithout being infected with HIV. , George Kassiot...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4A reductionist approach to HIV research 2The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant 54575 1The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant 54575 2The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant 54575 3The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant 54575 4The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant 54575 5Sex Hormone Levels Linked to Fractures in Men 54572 1Sex Hormone Levels Linked to Fractures in Men 54572 2AMDL Inc Files Notification of Late Filing for Form 10 Q 54569 1AMDL Inc Files Notification of Late Filing for Form 10 Q 54569 2(Date:11/30/2009)...ILLS, N.J., Nov. 30 Kemin Foods, L...Inc. and OmniActive Health Technologies, Ltd. ("Om...their dispute. The parties agree that Kemin,s US P...ocess for Isolation, Purification and Recrystalliz... and Uses Thereof" and the reissues of that patent...
(Date:11/30/2009)... MAR, Calif., Nov. 30 Am...ts: ADHC) is pleased to announce the appointment o...r to the Company,s Board of Directors. Mr. McEldow...period starting at the Chemical Bank in New York C... Bretall & McEldowney, San Francisco, an insti...
(Date:11/30/2009)... , PHILADELPHIA, Pennsylvania,...- Exclusive Updates From Elsevier,s Top Thought Le...A Momentum , Elsevier, a world leader in ...-based and electronic health record (EHR) integrat...e center for American Recovery and Reinvestment,Ac...
(Date:11/30/2009)... for Disease Control and Prevention estimate that ...are infected with HIV/AIDS. New research from Nort...se infected are minorities and do not have health ...strategy to facilitate education and prevention ef...The research, which analyzed 90,000 HIV patient ho...
(Date:11/30/2009)...f Navarra Hospital has launched a series of clinic...munotherapy treatment. This approach involves the ... healthy and tumour cells from the patient him or ...of the most aggressive and frequent malignant tumo...ing patients combined with the standard, first-lin...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6[0] OmniActive and Kemin Reach Amicable Settlement in Patent Dispute[0] American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company[0] Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog[0] Research highlights need for national HIV strategy[0] Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
careersUTEKpharmacogeneticastronomystymiediversionwiseBenitecTeradataanestheticslaunchingPewlaunchpadmascot
Other Tagspaucity 2erection 2prescribe 2prescribe 3prescribe 4prescribe 5prescribe 6prescribe 7prescribe 8prescribe 9prescribe 10formal 2formal 3formal 4formal 5formal 6formal 7highest 2highest 3highest 4highest 5highest 6highest 7highest 8highest 9cord 2cord 3cord 4cord 5cord 6saved 2infants 2infants 3infants 4infants 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |